| Emerging Drugs and Targets for Parkinson's Disease Contributor(s): Martinez, Ana (Editor), Gil, Carmen (Editor) |
|
 |
ISBN: 1849736170 ISBN-13: 9781849736176 Publisher: Royal Society of Chemistry OUR PRICE: $212.80 Product Type: Hardcover - Other Formats Published: July 2013 |
| Additional Information |
| BISAC Categories: - Medical | Neurology - Medical | Pharmacology - Medical | Internal Medicine |
| Dewey: 616.833 |
| Series: RSC Drug Discovery |
| Physical Information: 1.35" H x 6.4" W x 9.36" (1.68 lbs) 402 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: 1.Covers all aspects of Parkinson's disease drug research and emerging therapies. 2.Parkinson's deisaes affects over 1.5 million people worldwide and its prevalance is increasing with the agin population. 3.Medicinal chemists, pharmacologists, biochemists. 4.MedChemComm, Issues in Toxicology Series 5.Discusses new therapeutics for Parkinson's Disease under development, covering targetting, receptors as therapeutic targets and drug metabolism. |
Contributor Bio(s): Gil, Carmen: - Dr Carmen Gil is staff scientist at Center for Biological Research of Spanish National Council for Research (CSIC) with a background in Medicinal Chemistry and Pharmacy. She received her Ph.D. from Complutense University of Madrid in 2001. After a postdoctoral appointment at Bonn University (Germany) she joined the CSIC. Her research is oriented to the discovery and development of new small-molecules as innovative target-based drugs and her research areas have been focused on phosphodiesterase and kinase inhibitors as innovative drug candidates for neurodegenerative diseases. She is involved in different projects that apply her background and experience in the development of specific parasite phosphodiesterase and kinase inhibitors in the fight for neglected parasitic diseases. She is author of more than sixty scientific publications, has four active patents in the field and has contributed to several books. |